DCD for Lung Transplantation

  • Takahiro Oto


Lung transplantation has been performed as a well-accepted therapy for patients with various end-stage lung diseases [1]. Nonetheless, the wide spread of lung transplantation is limited by the donor shortage resulting in increasing number of deaths on waiting lists [2, 3].

Historically, the first attempts of most of solid organ transplants were from donation after cardiac death donor (DCD)/non-heart-beating donor (NHBD) [4, 5]. Since the introduction of brain death criteria, organs have been retrieved from brain-dead (heart-beating) donors. However, as a result of increasing donor shortage, there is now a renewed interest in DCD (NHBD) lung transplantation [6, 7]. DCD (NHBD) is expected to become the major source of organ supply in countries especially where the concept of brain death is not widely accepted by the public.

This chapter aims to describe the relevant published experimental evidences and recent clinical experiences with lung transplantation from DCD (NHBD).


Lung Transplantation Circulatory Arrest Warm Ischemia Bronchiolitis Obliterans Syndrome Warm Ischemic Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Meyers BF, Lynch J, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: a decade of experience. Ann Surg. 1999;230:362–70.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Oto T, et al. Registry of the Japanese society of lung and heart-lung transplantation: the official Japanese lung transplantation report 2012. Gen Thorac Cardiovasc Surg. 2013;61(4):208–11.PubMedCrossRefGoogle Scholar
  3. 3.
    Sung RS, Galloway J, Tuttle-Newhall JE, Tuttle-Newhall JE, Mone T, Laeng R, et al. Organ donation and utilization in the United States, 1997–2006. Am J Transplant. 2008;8:922–34.PubMedCrossRefGoogle Scholar
  4. 4.
    Kootstra G, Kievit J, Nederstigt A. Organ donors: heartbeating and non-heartbeating. World J Surg. 2002;26:181–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Hardy JD, Webb WR, Dalton Jr ML, Walker Jr GR. Lung homotransplantations in man. JAMA. 1963;186:1065–74.PubMedCrossRefGoogle Scholar
  6. 6.
    Love RB, Stringham JC, Chomiak PN. Successful lung transplantation using a non-heart-beating donor. J Heart Lung Transplant. 1995;14:S88 (abstr).Google Scholar
  7. 7.
    Steen S, Sjőberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357:825–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27:2893–4.PubMedGoogle Scholar
  9. 9.
    Steen S, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83:2191–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Cypel M, Yeung JC, Keshavjee S. Novel approaches to expanding the lung donor pool: donation after cardiac death and ex vivo conditioning. Clin Chest Med. 2011;32:233–44.PubMedCrossRefGoogle Scholar
  11. 11.
    de Antonio DG, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant. 2007;26:529–34.PubMedCrossRefGoogle Scholar
  12. 12.
    Oto T, et al. A practical approach to clinical lung transplantation from a Maastricht category III donor with cardiac death. J Heart Lung Transplant. 2007;26:196–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Snell GI, et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant. 2008;8:1282–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Orens JB, Boehler A, de Perrot M, Estenne M, Glanville AR, Keshavjee S, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22:1183–200.PubMedCrossRefGoogle Scholar
  15. 15.
    Steen S, Ingemansson R, Budrikis A, Bolys R, Roscher R, Sjőberg T. Successful transplantation of lungs topically cooled in the non-heart-beating donor for 6 hours. Ann Thorac Surg. 1997;63:345–51.PubMedCrossRefGoogle Scholar
  16. 16.
    Oto T, Excell L, Griffiths AP, Levvey BJ, Snell GI. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J Heart Lung Transplant. 2008;27:78–85.PubMedCrossRefGoogle Scholar
  17. 17.
    Oto T, Rabinov M, Griffiths AP, et al. Unexpected donor pulmonary embolism affects early outcomes after lung transplantation: a major mechanism of primary graft failure? J Thorac Cardiovasc Surg. 2005;130:1446.PubMedGoogle Scholar
  18. 18.
    Levvey BJ, Westall GP, Kotsimbos T, Williams TJ, Snell GI. Definitions of warm ischemic time when using controlled donation after cardiac death lung donors. Transplantation. 2008;86:1702–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Oto T. Lung transplantation from donation after cardiac death (non-heart-beating) donors. Gen Thorac Cardiovasc Surg. 2008;56:533–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Van Raemdonck DE, Jannis NC, De Leyn PR, Flameng WJ, Lerut TE. Warm ischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg. 1998;228:788–96.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Egan TM. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant. 2004;23:3–10.PubMedCrossRefGoogle Scholar
  22. 22.
    Rega FR, Neyrinck AP, Verleden GM, Lerut TE, Van Raemdonck DE. How long can we preserve the pulmonary graft inside the non-heart-beating donor? Ann Thorac Surg. 2004;77:438–44.PubMedCrossRefGoogle Scholar
  23. 23.
    Rega FR, Jannis NC, Verleden GM, Flameng WJ, Lerut TE, Van Raemdonck DE. Should we ventilate or cool the pulmonary graft inside the non-heart-beating donor? J Heart Lung Transplant. 2003;22:1226–33.PubMedCrossRefGoogle Scholar
  24. 24.
    Binns OA, DeLima NF, Buchanan SA, Mauney MC, Cope JT, Thies SD, et al. Impaired bronchial healing after lung donation from non-heart-beating donors. J Heart Lung Transplant. 1996;15:1084–92.PubMedGoogle Scholar
  25. 25.
    Miyoshi K, Oto T, Otani S, et al. Effect of donor pre-mortem hypoxia and hypotension on graft function and start of warm ischemia in donation after cardiac death lung transplantation. J Heart Lung Transplant. 2011;30:445–51.PubMedCrossRefGoogle Scholar
  26. 26.
    Otani S, Oto T, Kakishita T, et al. Early effects of the ex vivo evaluation system on graft function after swine lung transplantation. Eur J Cardiothorac Surg. 2011;40:956–61.PubMedGoogle Scholar
  27. 27.
    Yeung JC, Cypel M, Machuca TN, et al. Physiologic assessment of the ex vivo donor lung for transplantation. J Heart Lung Transplant. 2012;31:1120–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Geudens N, Van de Wauwer C, Neyrinck AP, Timmermans L, Vanhooren HM, Vanaudenaerde BM, et al. N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. J Heart Lung Transplant. 2007;26:1326–32.PubMedCrossRefGoogle Scholar
  29. 29.
    Oto T, Calderone A, Pepe S, Snell G, Rosenfeldt F. High-flow endobronchial cooled humidified air protects non-heart-beating donor rat lungs against warm ischemia. J Thorac Cardiovasc Surg. 2006;132:413–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Yoshida S, Sekine Y, Shinozuka N, Satoh J, Yasufuku K, Iwata T, et al. The efficacy of partial liquid ventilation in lung protection during hypotension and cardiac arrest: preliminary study of lung transplantation using non-heart-beating donors. J Heart Lung Transplant. 2005;24:723–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Wittwer T, Franke UF, Sandhaus T, Groetzner J, Strauch JT, Wippermann J, et al. Endobronchial donor pre-treatment with ventavis: is a second administration during reperfusion beneficial to optimize post-ischemic function of non-heart-beating donor lungs? J Surg Res. 2006;136:136–42.PubMedCrossRefGoogle Scholar
  32. 32.
    Chen F, Nakamura T, Fujinaga T, Zhang J, Hamakawa H, Omasa M, et al. Protective effect of a nebulized beta2-adorenoreceptor agonist in warm ischemic-reperfused rat lungs. Ann Thorac Surg. 2006;82:465–71.PubMedCrossRefGoogle Scholar
  33. 33.
    Egan TM, Hoffmann SC, Sevala M, Sadoff JD, Schlidt SA. Nitroglycerin reperfusion reduces ischemia-reperfusion injury in non-heart-beating donor lungs. J Heart Lung Transplant. 2006;25:110–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Takashima S, Koukoilis G, Inokawa H, Sevala M, Egan TM. Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non-heart-beating donors. J Thorac Cardiovasc Surg. 2006;132:132–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Department of Thoracic SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmacological SciencesOkayama, Kita-kuJapan

Personalised recommendations